Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells
Cancer Cell · 2024
DOI: 10.1016/j.ccell.2024.07.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024. Verfasst von Yijun Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA; Cancer Epigenetic Institu…. Hauptthemen laut MEDLINE: Medulloblastoma, Cell Differentiation, Enhancer of Zeste Homolog 2 Protein, Thyroid Hormones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA; Cancer Epigenetic Institute, Fox Chase Cancer Center, Temple University Health System, Philadel…
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
- Department of Pathology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
- Department of Medicine, Division of Endocrinology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA.
- Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University Health System, Philadelphia, PA 19140, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- Andrew McDonough B+ Foundation
- National Key Research and Development Program of China
- American Cancer Society
- Comprehensive Cancer Center, University of Chicago Medical Center
- CURE Childhood Cancer Association
Zitieren
APA
Yang, Y., Valdés-Rives, S. A., Liu, Q., Gao, T., Burudpakdee, C., Li, Y., Tan, J., Tan, Y., Koch, C. A., Rong, Y., Houser, S. R., Wei, S., Cai, K. Q., Wu, J., Cheng, S. Y., Wechsler-Reya, R., & Yang, Z. J. (2024). Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.07.008
Vancouver
Yang Y, Valdés-Rives SA, Liu Q, Gao T, Burudpakdee C, Li Y, et al. Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.07.008
BibTeX
@article{Yang2024,
author = {Yang, Yijun and Valdés-Rives, Silvia Anahi and Liu, Qing and Gao, Tong and Burudpakdee, Chakkapong and Li, Yuzhe and Tan, Jun and Tan, Yinfei and Koch, Christian A and Rong, Yuan and Houser, Steven R and Wei, Shuanzeng and Cai, Kathy Q and Wu, Jinhua and Cheng, Sheue-Yann and Wechsler-Reya, Robert and Yang, Zeng-Jie},
title = {Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.07.008}
}
EUVIMED